Document:

Form of Debt Securities Warrant Agreement

 Exhibit 4.13 
  
 CELL THERAPEUTICS, INC. 
  
 and 
  
 [                                      
  ], as Warrant Agent 
  
 FORM OF DEBT SECURITIES

 WARRANT AGREEMENT 
  
 Dated as of 
 [                                      
  ] 

 TABLE OF CONTENTS 
  

					
	 	  	 	  	Page

	ARTICLE 1	  	     ISSUANCE OF WARRANTS AND EXECUTION AND DELIVERY OF WARRANT CERTIFICATES
	  	1
			
	1.1    	  	 Issuance of Warrants
	  	1
			
	1.2    	  	 Execution and Delivery of Warrant Certificates
	  	2
			
	1.3    	  	 Issuance of Warrant Certificates
	  	2
			
	ARTICLE 2	  	     WARRANT PRICE, DURATION AND EXERCISE OF WARRANTS
	  	3
			
	2.1    	  	 Warrant Price
	  	3
			
	2.2    	  	 Duration of Warrants
	  	3
			
	2.3    	  	 Exercise of Warrants
	  	3
			
	ARTICLE 3	  	     OTHER PROVISIONS RELATING TO RIGHTS OF HOLDERS OF WARRANT CERTIFICATES
	  	4
			
	3.1    	  	 No Rights as Holders of Warrant Debt Securities Conferred by Warrants or Warrant Certificates
	  	4
			
	3.2    	  	 Lost, Stolen, Mutilated or Destroyed Warrant Certificates
	  	5
			
	3.3    	  	 Holder of Warrant Certificate May Enforce Rights
	  	5
			
	3.4    	  	 Merger, Sale, Conveyance or Lease
	  	5
			
	3.5    	  	 Notice to Warrantholders
	  	6
			
	ARTICLE 4	  	     EXCHANGE AND TRANSFER OF WARRANT CERTIFICATES
	  	6
			
	4.1    	  	 Exchange and Transfer of Warrant Certificates
	  	6
			
	4.2    	  	 Treatment of Holders of Warrant Certificates
	  	7
			
	4.3    	  	 Cancellation of Warrant Certificates
	  	7
			
	ARTICLE 5	  	     CONCERNING THE WARRANT AGENT
	  	7
			
	5.1    	  	 Warrant Agent
	  	7
			
	5.2    	  	 Conditions of Warrant Agent’s Obligations
	  	8
			
	5.3    	  	 Resignation, Removal and Appointment of Successors
	  	9
			
	ARTICLE 6	  	     MISCELLANEOUS
	  	10
			
	6.1    	  	 Amendment
	  	10
			
	6.2    	  	 Notices and Demands to the Company and Warrant Agent
	  	11
			
	6.3    	  	 Addresses
	  	11
			
	6.4    	  	 Governing Law
	  	11

  

 -i- 

 TABLE OF CONTENTS 
 (continued) 
  

					
	 	  	 	  	Page

	6.5    	  	 Delivery of Prospectus
	  	11
			
	6.6    	  	 Obtaining of Governmental Approvals
	  	11
			
	6.7    	  	 Persons Having Rights Under Warrant Agreement
	  	11
			
	6.8    	  	 Headings
	  	11
			
	6.9    	  	 Counterparts
	  	12
			
	6.10  	  	 Inspection of Agreement
	  	12

  

 -ii- 

 CELL THERAPEUTICS, INC. 
 Form of Debt Securities Warrant Agreement 
  
 DEBT SECURITIES WARRANT AGREEMENT, dated as of
                                     between Cell Therapeutics, Inc.,
a Washington corporation (the “Company”) and                         , a [corporation] [national banking
association] organized and existing under the laws of and having a corporate trust office in                     , as warrant agent (the
“Warrant Agent”). 
  
 WHEREAS, the
Company has entered into an indenture dated as of
[                                     (the “Senior
Indenture”), with                          , as trustee (such trustee, and any successors to such trustee, herein
called the “Senior Trustee”), providing for the issuance from time to time of its unsubordinated debt securities, to be issued in one or more series as provided in the Senior Indenture (the “Debt
Securities”);] [                         (the “Subordinated Indenture”), with
                        , as trustee (such trustee, and any successors to such trustee, herein called the
“Subordinated Trustee”), providing for the issuance from time to time of its subordinated debt securities, to be issued in one or more series as provided in the Subordinated Indenture (the “Debt
Securities”);] 
  
 WHEREAS, the Company
proposes to sell [If Warrants are sold with other securities—title of such other Securities being offered (the “Other Securities”) with] warrant certificates evidencing one or more warrants (the
“Warrants” or, individually, a “Warrant”) representing the right to purchase [title of Debt Securities purchasable through exercise of Warrants] (the “Warrant Debt Securities”),
such warrant certificates and other warrant certificates issued pursuant to this Agreement being herein called the “Warrant Certificates”; and 
  
 WHEREAS, the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing so
to act, in connection with the issuance, registration, transfer, exchange, exercise and replacement of the Warrant Certificates, and in this Agreement wishes to set forth, among other things, the form and provisions of the Warrant Certificates and
the terms and conditions on which they may be issued, registered, transferred, exchanged, exercised and replaced; 
  
 NOW, THEREFORE, in consideration of the premises and of the mutual agreements herein contained, the parties hereto agree as follows: 
  
 ARTICLE 1 
  
 ISSUANCE OF WARRANTS AND EXECUTION AND 
 DELIVERY OF WARRANT CERTIFICATES 
  
 1.1 Issuance of Warrants. [If Warrants alone—Upon issuance, each Warrant Certificate shall evidence one or more Warrants.] [If Other
Securities and Warrants—Warrant Certificates shall be [initially] issued in connection with the issuance of the Other Securities [but shall be separately transferable on and after
                         (the “Detachable Date”)] [and shall not be separately transferable] and each
Warrant Certificate shall evidence one or more Warrants.] Each Warrant evidenced thereby shall represent the right, subject to the provisions contained herein and therein, to purchase one Warrant Debt Security. [If Other Securities and
Warrants— 

 
Warrant Certificates shall be initially issued in units with the Other Securities and each Warrant Certificate included in such a unit shall evidence
                         Warrants for each [$             principal
amount] [                         shares] of Other Securities included in such unit.]. 
  
 1.2 Execution and Delivery of Warrant Certificates. Each Warrant
Certificate, whenever issued, shall be in registered form substantially in the form set forth in Exhibit A hereto, shall be dated the date of its countersignature by the Warrant Agent and may have such letters, numbers, or other marks of
identification or designation and such legends or endorsements printed, lithographed or engraved thereon as the officers of the Company executing the same may approve (execution thereof to be conclusive evidence of such approval) and as are not
inconsistent with the provisions of this Agreement, or as may be required to comply with any law or with any rule or regulation made pursuant thereto or with any rule or regulation of any securities exchange on which the Warrants may be listed, or
to conform to usage. The Warrant Certificates shall be signed on behalf of the Company by any of its present or future chief executive officers, presidents, executive vice presidents, vice presidents, chief financial officers, chief legal officers,
treasurers, assistant treasurers, controllers, assistant controllers, secretaries or assistant secretaries under its corporate seal reproduced thereon. Such signatures may be manual or facsimile signatures of such authorized officers and may be
imprinted or otherwise reproduced on the Warrant Certificates. The seal of the Company may be in the form of a facsimile thereof and may be impressed, affixed, imprinted or otherwise reproduced on the Warrant Certificates. 
  
 No Warrant Certificate shall be valid for any purpose, and no Warrant
evidenced thereby shall be exercisable, until such Warrant Certificate has been countersigned by the manual signature of the Warrant Agent. Such signature by the Warrant Agent upon any Warrant Certificate executed by the Company shall be conclusive
evidence that the Warrant Certificate so countersigned has been duly issued hereunder. 
  
 In case any officer of the Company who shall have signed any of the Warrant Certificates either manually or by facsimile signature shall cease to be such officer before the Warrant Certificates so signed shall have
been countersigned and delivered by the Warrant Agent, such Warrant Certificates may be countersigned and delivered notwithstanding that the person who signed Warrant Certificates ceased to be such officer of the Company; and any Warrant Certificate
may be signed on behalf of the Company by such persons as, at the actual date of the execution of such Warrant Certificate, shall be the proper officers of the Company, although at the date of the execution of this Agreement any such person was not
such officer. 
  
 The term “holder” or “holder of a
Warrant Certificate” as used herein shall mean any person in whose name at the time any Warrant Certificate shall be registered upon the books to be maintained by the Warrant Agent for that purpose [If Other Securities and Warrants are not
immediately detachable—or upon the registration of the Other Securities prior to the Detachable Date. Prior to the Detachable Date, the Company will, or will cause the registrar of the Other Securities to, make available at all times to the
Warrant Agent such information as to holders of the Other Securities as may be necessary to keep the Warrant Agent’s records up to date]. 
  
 1.3 Issuance of Warrant Certificates. Warrant Certificates evidencing the right to purchase Warrant Debt Securities may be executed by the Company
and delivered to the 

  

 -2- 

 
Warrant Agent upon the execution of this Warrant Agreement or from time to time thereafter. The Warrant Agent shall, upon receipt of Warrant Certificates
duly executed on behalf of the Company, countersign such Warrant Certificates and shall deliver such Warrant Certificates to or upon the order of the Company. 
  

ARTICLE 2 
  
 WARRANT PRICE, DURATION AND EXERCISE OF WARRANTS 
  
 2.1 Warrant Price. During the period specified in Section 2.2, each Warrant shall, subject to the terms of this Warrant Agreement and the
applicable Warrant Certificate, entitle the holder thereof, to purchase the principal amount of Warrant Debt Securities specified in the applicable Warrant Certificate at an exercise price of
            % of the principal amount thereof [plus accrued amortization, if any, of the original issue discount of the Warrant Debt Securities] [plus accrued interest, if any, from the
most recent date from which interest shall have been paid on the Warrant Debt Securities or, if no interest shall have been paid on the Warrant Debt Securities, from the date of their initial issuance.] [The original issue discount
($             for each $1,000 principal amount of Warrant Debt Securities) will be amortized at a             % annual rate,
computed on a[n] [semi-] annual basis [using a 360-day year consisting of twelve 30-day months].] Such purchase price for the Warrant Debt Securities is referred to in this Agreement as the “Warrant Price.” 
  
 2.2 Duration of Warrants. Each Warrant may be exercised in whole or in
part at any time, as specified herein, on or after [the date thereof] [            ] and at or before [            ] p.m., [City]
time, on              or such later date as the Company may designate by notice to the Warrant Agent and the holders of Warrant Certificates mailed to their addresses as set forth in the
record books of the Warrant Agent (the “Expiration Date”). Each Warrant not exercised at or before [            ] p.m., [City] time, on the Expiration Date shall become void, and
all rights of the holder of the Warrant Certificate evidencing such Warrant under this Agreement shall cease. 
  
 2.3 Exercise of Warrants. 
  
 (a) During the period specified in Section 2.2, the Warrants may be exercised to purchase a whole number of Warrant Debt Securities in registered
form by providing certain information as set forth on the reverse side of the Warrant Certificate and by paying in full, in lawful money of the United States of America, [in cash or by certified check or official bank check in New York Clearing
House funds] [by bank wire transfer in immediately available funds] the Warrant Price for each Warrant Debt Security with respect to which a Warrant is being exercised to the Warrant Agent at its corporate trust office, provided that such
exercise is subject to receipt within five business days of such payment by the Warrant Agent of the Warrant Certificate with the form of election to purchase Warrant Debt Securities set forth on the reverse side of the Warrant Certificate properly
completed and duly executed. The date on which payment in full of the Warrant Price is received by the Warrant Agent shall, subject to receipt of the Warrant Certificate as aforesaid, be deemed to be the date on which the Warrant is exercised;
provided, however, that if, at the date of receipt of such Warrant Certificates and payment in full 

  

 -3- 

 
of the Warrant Price, the transfer books for the Warrant Debt Securities purchasable upon the exercise of such Warrants shall be closed, no such receipt of
such Warrant Certificates and no such payment of such Warrant Price shall be effective to constitute the person so designated to be named as the holder of record of such Warrant Debt Securities on such date, but shall be effective to constitute such
person as the holder of record of such Warrant Debt Securities for all purposes at the opening of business on the next succeeding day on which the transfer books for the Warrant Debt Securities purchasable upon the exercise of such Warrants shall be
opened, and the certificates for the Warrant Debt Securities in respect of which such Warrants are then exercised shall be issuable as of the date on such next succeeding day on which the transfer books shall next be opened, and until such date the
Company shall be under no duty to deliver any certificate for such Warrant Debt Securities. The Warrant Agent shall deposit all funds received by it in payment of the Warrant Price in an account of the Company maintained with it and shall advise the
Company by telephone at the end of each day on which a payment for the exercise of Warrants is received of the amount so deposited to its account. The Warrant Agent shall promptly confirm such telephone advice to the Company in writing. 

 
 (b) The Warrant Agent shall, from time to time, as promptly as
practicable, advise the Company of (i) the number of Warrant Debt Securities with respect to which Warrants were exercised, (ii) the instructions of each holder of the Warrant Certificates evidencing such Warrants with respect to delivery
of the Warrant Debt Securities to which such holder is entitled upon such exercise, (iii) delivery of Warrant Certificates evidencing the balance, if any, of the Warrants for the remaining Warrant Debt Securities after such exercise, and
(iv) such other information as the Company or the [Senior] [Subordinated] Trustee shall reasonably require. 
  
 (c) As soon as practicable after the exercise of any Warrant, the Company shall issue, pursuant to the Indenture, in authorized denominations, to or upon
the order of the holder of the Warrant Certificate evidencing such Warrant, the Warrant Debt Securities to which such holder is entitled, in fully registered form, registered in such name or names as may be directed by such holder. If fewer than all
of the Warrants evidenced by such Warrant Certificate were exercised, the Company shall execute, and an authorized officer of the Warrant Agent shall manually countersign and deliver, a new Warrant Certificate evidencing Warrants for the number of
Warrant Debt Securities remaining unexercised. 
  
 (d) The Company
shall not be required to pay any stamp or other tax or other governmental charge required to be paid in connection with any transfer involved in the issue of the Warrant Debt Securities, and in the event that any such transfer is involved, the
Company shall not be required to issue or deliver any Warrant Debt Securities until such tax or other charge shall have been paid or it has been established to the Company’s satisfaction that no such tax or other charge is due. 
  
 ARTICLE 3 
  
 OTHER PROVISIONS RELATING TO RIGHTS OF 
 HOLDERS OF WARRANT CERTIFICATES 
  
 3.1 No Rights as Holders of Warrant Debt Securities Conferred by Warrants or Warrant Certificates. No Warrant Certificate or Warrant evidenced
thereby shall 

  

 -4- 

 
entitle the holder thereof to any of the rights of a holder of Warrant Debt Securities, including, without limitation, the right to receive the payment of
principal of (or premium, if any) or interest, if any, on the Warrant Debt Securities or to enforce any of the covenants in the Indenture. 
  
 3.2 Lost, Stolen, Mutilated or Destroyed Warrant Certificates. Upon receipt by the Warrant Agent of evidence reasonably satisfactory to it and the
Company of the ownership of and the loss, theft, destruction or mutilation of any Warrant Certificate and/or indemnity reasonably satisfactory to the Warrant Agent and the Company and, in the case of mutilation, upon surrender of the mutilated
Warrant Certificate to the Warrant Agent for cancellation, then, in the absence of notice to the Company or the Warrant Agent that such Warrant Certificate has been acquired by a bona fide purchaser, the Company shall execute, and an authorized
officer of the Warrant Agent shall manually countersign and deliver, in exchange for or in lieu of the lost, stolen, destroyed or mutilated Warrant Certificate, a new Warrant Certificate of the same tenor and evidencing Warrants for a like principal
amount of Warrant Debt Securities. Upon the issuance of any new Warrant Certificate under this Section 3.2, the Company may require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation
thereto and any other expenses (including the fees and expenses of the Warrant Agent) in connection therewith. Every substitute Warrant Certificate executed and delivered pursuant to this Section 3.2 in lieu of any lost, stolen or destroyed
Warrant Certificate shall represent an additional contractual obligation of the Company, whether or not the lost, stolen or destroyed Warrant Certificate shall be at any time enforceable by anyone, and shall be entitled to the benefits of this
Agreement equally and proportionately with any and all other Warrant Certificates duly executed and delivered hereunder. The provisions of this Section 3.2 are exclusive and shall preclude (to the extent lawful) all other rights and remedies
with respect to the replacement of mutilated, lost, stolen or destroyed Warrant Certificates. 
  
 3.3 Holder of Warrant Certificate May Enforce Rights. Notwithstanding any of the provisions of this Agreement, any holder of any Warrant Certificate, without the consent of the Warrant Agent, the [Senior]
[Subordinated] Trustee, the holder of any Warrant Debt Securities or the holder of any other Warrant Certificate, may, in such holder’s own behalf and for such holder’s own benefit, enforce, and may institute and maintain any suit, action
or proceeding against the Company suitable to enforce, or otherwise in respect of, such holder’s right to exercise the Warrants evidenced by such holder’s Warrant Certificate in the manner provided in such holder’s Warrant
Certificates and in this Agreement. 
  
 3.4 Merger, Sale,
Conveyance or Lease. In case of (a) any share exchange, merger or similar transaction of the Company with or into another person or entity (other than a share exchange, merger or similar transaction in which the Company is the acquiring or
surviving corporation) or (b) the sale, exchange, lease, transfer or other disposition of all or substantially all of the properties and assets of the Company as an entirety (in any such case, a “Reorganization Event”),
then, as a condition of such Reorganization Event, lawful provisions shall be made, and duly executed documents evidencing the same from the Company’s successor shall be delivered to the holders of the Warrants, so that such successor shall
succeed to and be substituted for the Company, and assume all the Company’s obligations under, this Agreement and the Warrants. The Company shall thereupon be relieved of any further obligation hereunder 

  

 -5- 

 
or under the Warrants, and the Company as the predecessor corporation may thereupon or at any time thereafter be dissolved, wound up or liquidated. Such
successor or assuming entity thereupon may cause to be signed, and may issue either in its own name or in the name of the Company, any or all of the Warrants issuable hereunder which heretofore shall not have been signed by the Company, and may
execute and deliver securities in its own name, in fulfillment of its obligations to deliver Warrant Debt Securities upon exercise of the Warrants. All the Warrants so issued shall in all respects have the same legal rank and benefit under this
Agreement as the Warrants theretofore or thereafter issued in accordance with the terms of this Agreement as though all of such Warrants had been issued at the date of the execution hereof. In any case of any such Reorganization Event, such changes
in phraseology and form (but not in substance) may be made in the Warrants thereafter to be issued as may be appropriate. 
  
 The Warrant Agent may receive a written opinion of legal counsel as conclusive evidence that any such Reorganization Event complies with the provisions of
this Section 3.4. 
  
 3.5 Notice to Warrantholders. In
case the Company shall (a) effect any Reorganization Event or (b) make any distribution on or in respect of the [title of Warrant Debt Securities] in connection with the dissolution, liquidation or winding up of the Company, then the
Company shall mail to each holder of Warrants at such holder’s address as it shall appear on the books of the Warrant Agent, at least ten days prior to the applicable date hereinafter specified, a notice stating the date on which such
Reorganization Event, dissolution, liquidation or winding up is expected to become effective, and the date as of which it is expected that holders of [title of Warrant Debt Securities] of record shall be entitled to exchange their shares of [title
of Warrant Debt Securities] for securities or other property deliverable upon such Reorganization Event, dissolution, liquidation or winding up. No failure to mail such notice nor any defect therein or in the mailing thereof shall affect any such
transaction. 
  
 ARTICLE 4 
  
 EXCHANGE AND TRANSFER OF WARRANT CERTIFICATES 
  
 4.1 Exchange and Transfer of Warrant Certificates. [If Other
Securities with Warrants which are immediately detachable—Upon] [If Other Securities with Warrants which are not immediately detachable—Prior to the Detachable Date, a Warrant Certificate may be exchanged or transferred only together with
the Other Security to which the Warrant Certificate was initially attached, and only for the purpose of effecting or in conjunction with an exchange or transfer of such Other Security. Prior to any Detachable Date, each transfer of the Other
Security shall operate also to transfer the related Warrant Certificates. After the Detachable Date, upon] surrender at the corporate trust office of the Warrant Agent, Warrant Certificates evidencing Warrants may be exchanged for Warrant
Certificates in other denominations evidencing such Warrants or the transfer thereof may be registered in whole or in part; provided that such other Warrant Certificates evidence Warrants for the same aggregate principal amount of Warrant
Debt Securities as the Warrant Certificates so surrendered. The Warrant Agent shall keep, at its corporate trust office, books in which, subject to such reasonable regulations as it may prescribe, it shall register Warrant Certificates and exchanges
and transfers of outstanding Warrant Certificates, upon surrender of the Warrant Certificates to the Warrant Agent at its corporate trust office for exchange or registration of transfer, properly endorsed or 

  

 -6- 

 
accompanied by appropriate instruments of registration of transfer and written instructions for transfer, all in form satisfactory to the Company and the
Warrant Agent. No service charge shall be made for any exchange or registration of transfer of Warrant Certificates, but the Company may require payment of a sum sufficient to cover any stamp or other tax or other governmental charge that may be
imposed in connection with any such exchange or registration of transfer. Whenever any Warrant Certificates are so surrendered for exchange or registration of transfer, an authorized officer of the Warrant Agent shall manually countersign and
deliver to the person or persons entitled thereto a Warrant Certificate or Warrant Certificates duly authorized and executed by the Company, as so requested. The Warrant Agent shall not be required to effect any exchange or registration of transfer
which will result in the issuance of a Warrant Certificate evidencing a Warrant for a fraction of a Warrant Debt Security or a number of Warrants for a whole number of Warrant Debt Securities and a fraction of a Warrant Debt Security. All Warrant
Certificates issued upon any exchange or registration of transfer of Warrant Certificates shall be the valid obligations of the Company, evidencing the same obligations and entitled to the same benefits under this Agreement as the Warrant
Certificate surrendered for such exchange or registration of transfer. 
  
 4.2 Treatment of Holders of Warrant Certificates. [If Other Securities and Warrants are not immediately detachable—Prior to the Detachable Date, the Company, the Warrant Agent and all other persons may treat the owner of the
Other Security as the owner of the Warrant Certificates initially attached thereto for any purpose and as the person entitled to exercise the rights represented by the Warrants evidenced by such Warrant Certificates, any notice to the contrary
notwithstanding. After the Detachable Date and prior to due presentment of a Warrant Certificate for registration of transfer, the] [The] Company, the Warrant Agent and all other persons may treat the registered holder of a Warrant Certificate as
the absolute owner thereof for any purpose and as the person entitled to exercise the rights represented by the Warrants evidenced thereby, any notice to the contrary notwithstanding. 
  
 4.3 Cancellation of Warrant Certificates. Any Warrant Certificate surrendered for exchange, registration of transfer
or exercise of the Warrants evidenced thereby shall, if surrendered to the Company, be delivered to the Warrant Agent and all Warrant Certificates surrendered or so delivered to the Warrant Agent shall be promptly canceled by the Warrant Agent and
shall not be reissued and, except as expressly permitted by this Agreement, no Warrant Certificate shall be issued hereunder in exchange therefor or in lieu thereof. The Warrant Agent shall deliver to the Company from time to time or otherwise
dispose of canceled Warrant Certificates in a manner satisfactory to the Company. 
  
 ARTICLE 5 
  
 CONCERNING
THE WARRANT AGENT 
  
 5.1 Warrant Agent. The Company
hereby appoints                  as Warrant Agent of the Company in respect of the Warrants and the Warrant Certificates upon the terms and subject to the conditions
herein set forth, and                  hereby accepts such appointment. The Warrant Agent shall have the powers and authority granted to and conferred upon it in the
Warrant Certificates and hereby and such further power and authority to act on behalf of the Company as the Company may hereafter grant to or confer upon it. All of the terms and provisions with respect to such power and authority contained in the
Warrant Certificates are subject to and governed by the terms and provisions hereof. 
  

 -7- 

 5.2 Conditions of Warrant Agent’s Obligations. The Warrant Agent accepts its obligations
herein set forth upon the terms and conditions hereof, including the following to all of which the Company agrees and to all of which the rights hereunder of the holders from time to time of the Warrant Certificates shall be subject: 
  
 (a) Compensation and Indemnification. The Company agrees promptly to
pay the Warrant Agent the compensation to be agreed upon with the Company for all services rendered by the Warrant Agent and to reimburse the Warrant Agent for reasonable out-of-pocket expenses (including reasonable counsel fees) incurred without
negligence, bad faith or willful misconduct by the Warrant Agent in connection with the services rendered hereunder by the Warrant Agent. The Company also agrees to indemnify the Warrant Agent for, and to hold it harmless against, any loss,
liability or expense incurred without negligence, bad faith or willful misconduct on the part of the Warrant Agent, arising out of or in connection with its acting as Warrant Agent hereunder, including the reasonable costs and expenses of defending
against any claim of such liability. 
  
 (b) Agent for the
Company. In acting under this Warrant Agreement and in connection with the Warrant Certificates, the Warrant Agent is acting solely as agent of the Company and does not assume any obligations or relationship of agency or trust for or with any of
the holders of Warrant Certificates or beneficial owners of Warrants. 
  
 (c) Counsel. The Warrant Agent may consult with counsel satisfactory to it, which may include counsel for the Company, and the written advice of such counsel shall be full and complete authorization and protection in respect of any
action taken, suffered or omitted by it hereunder in good faith and in accordance with the advice of such counsel. 
  
 (d) Documents. The Warrant Agent shall be protected and shall incur no liability for or in respect of any action taken or omitted by it in reliance
upon any Warrant Certificate, notice, direction, consent, certificate, affidavit, statement or other paper or document reasonably believed by it to be genuine and to have been presented or signed by the proper parties. 
  
 (e) Certain Transactions. The Warrant Agent, and its officers,
directors and employees, may become the owner of, or acquire any interest in, Warrants, with the same rights that it or they would have if it were not the Warrant Agent hereunder, and, to the extent permitted by applicable law, it or they may engage
or be interested in any financial or other transaction with the Company and may act on, or as depositary, trustee or agent for, any committee or body of holders of Warrant Securities or other obligations of the Company as freely as if it were not
the Warrant Agent hereunder. Nothing in this Warrant Agreement shall be deemed to prevent the Warrant Agent from acting as [Senior] [Subordinated] Trustee under the [Senior] [Subordinated] Indenture. 
  

 -8- 

 (f) No Liability for Interest. Unless otherwise agreed with the Company, the Warrant Agent shall
have no liability for interest on any monies at any time received by it pursuant to any of the provisions of this Agreement or of the Warrant Certificates. 
  
 (g) No Liability for Invalidity. The Warrant Agent shall have no liability with respect to any invalidity of this Agreement or any of the Warrant
Certificates (except as to the Warrant Agent’s countersignature thereon). 
  
 (h) No Responsibility for Representations. The Warrant Agent shall not be responsible for any of the recitals or representations herein or in the Warrant Certificates (except as to the Warrant Agent’s
countersignature thereon), all of which are made solely by the Company. 
  
 (i) No Implied Obligations. The Warrant Agent shall be obligated to perform only such duties as are herein and in the Warrant Certificates specifically set forth and no implied duties or obligations shall be read into this Agreement
or the Warrant Certificates against the Warrant Agent. The Warrant Agent shall not be under any obligation to take any action hereunder which may tend to involve it in any expense or liability, the payment of which within a reasonable time is not,
in its reasonable opinion, assured to it. The Warrant Agent shall not be accountable or under any duty or responsibility for the use by the Company of any of the Warrant Certificates authenticated by the Warrant Agent and delivered by it to the
Company pursuant to this Agreement or for the application by the Company of the proceeds of the Warrant Certificates. The Warrant Agent shall have no duty or responsibility in case of any default by the Company in the performance of its covenants or
agreements contained herein or in the Warrant Certificates or in the case of the receipt of any written demand from a holder of a Warrant Certificate with respect to such default, including, without limiting the generality of the foregoing, any duty
or responsibility to initiate or attempt to initiate any proceedings at law or otherwise or, except as provided in Section 6.2 hereof, to make any demand upon the Company. 
  
 5.3 Resignation, Removal and Appointment of Successors. 
  
 (a) The Company agrees, for the benefit of the holders from time to time of
the Warrant Certificates, that there shall at all times be a Warrant Agent hereunder until all the Warrants have been exercised or are no longer exercisable. 
  
 (b) The Warrant Agent may at any time resign as agent by giving written notice to the Company of such intention on its part, specifying the date on which
its desired resignation shall become effective; provided that such date shall not be less than three months after the date on which such notice is given unless the Company otherwise agrees. The Warrant Agent hereunder may be removed at any
time by the filing with it of an instrument in writing signed by or on behalf of the Company and specifying such removal and the intended date when it shall become effective. Such resignation or removal shall take effect upon the appointment by the
Company, as hereinafter provided, of a successor Warrant Agent (which shall be a bank or trust company authorized under the laws of the jurisdiction of its organization to exercise corporate trust powers) and the acceptance of such appointment by
such successor Warrant Agent. The obligation of the Company under Section 5.2(a) shall continue to the extent set forth therein notwithstanding the resignation or removal of the Warrant Agent. 
  

 -9- 

 (c) In case at any time the Warrant Agent shall resign, or shall be removed, or shall become incapable of
acting, or shall be adjudged a bankrupt or insolvent, or shall commence a voluntary case under the Federal bankruptcy laws, as now or hereafter constituted, or under any other applicable Federal or state bankruptcy, insolvency or similar law or
shall consent to the appointment of or taking possession by a receiver, custodian, liquidator, assignee, trustee, sequestrator (or other similar official) of the Warrant Agent or its property or affairs, or shall make an assignment for the benefit
of creditors, or shall admit in writing its inability to pay its debts generally as they become due, or shall take corporate action in furtherance of any such action, or a decree or order for relief by a court having jurisdiction in the premises
shall have been entered in respect of the Warrant Agent in an involuntary case under the Federal bankruptcy laws, as now or hereafter constituted, or any other applicable Federal or state bankruptcy, insolvency or similar law, or a decree or order
by a court having jurisdiction in the premises shall have been entered for the appointment of a receiver, custodian, liquidator, assignee, trustee, sequestrator (or similar official) of the Warrant Agent or of its property or affairs, or any public
officer shall take charge or control of the Warrant Agent or of its property or affairs for the purpose of rehabilitation, conservation, winding up or liquidation, a successor Warrant Agent, qualified as aforesaid, shall be appointed by the Company
by an instrument in writing, filed with the successor Warrant Agent. Upon the appointment as aforesaid of a successor Warrant Agent and acceptance by the successor Warrant Agent of such appointment, the Warrant Agent shall cease to be Warrant Agent
hereunder. 
  
 (d) Any successor Warrant Agent appointed hereunder
shall execute, acknowledge and deliver to its predecessor and to the Company an instrument accepting such appointment hereunder, and thereupon such successor Warrant Agent, without any further act, deed or conveyance, shall become vested with all
the authority, rights, powers, trusts, immunities, duties and obligations of such predecessor with like effect as if originally named as Warrant Agent hereunder, and such predecessor, upon payment of its charges and disbursements then unpaid, shall
thereupon become obligated to transfer, deliver and pay over, and such successor Warrant Agent shall be entitled to receive, all monies, securities and other property on deposit with or held by such predecessor, as Warrant Agent hereunder.

  
 (e) Any corporation into which the Warrant Agent hereunder may
be merged or converted or any corporation with which the Warrant Agent may be consolidated, or any corporation resulting from any merger, conversion or consolidation to which the Warrant Agent shall be a party, or any corporation to which the
Warrant Agent shall sell or otherwise transfer all or substantially all the assets and business of the Warrant Agent, provided that it shall be qualified as aforesaid, shall be the successor Warrant Agent under this Agreement without the
execution or filing of any paper or any further act on the part of any of the parties hereto. 
  
 ARTICLE 6 
  
 MISCELLANEOUS 
  
 6.1 Amendment. This
Agreement may be amended by the parties hereto, without the consent of the holder of any Warrant Certificate, for the purpose of curing any ambiguity, or of curing, correcting or supplementing any defective provision contained herein, or making any
other provisions with respect to matters or questions arising under this Agreement as the Company and the Warrant Agent may deem necessary or desirable; provided that such action shall not materially adversely affect the interests of the holders of
the Warrant Certificates. 
  

 -10- 

 6.2 Notices and Demands to the Company and Warrant Agent. If the Warrant Agent shall receive any
notice or demand addressed to the Company by the holder of a Warrant Certificate pursuant to the provisions of the Warrant Certificates, the Warrant Agent shall promptly forward such notice or demand to the Company. 
  
 6.3 Addresses. Any communication from the Company to the Warrant Agent
with respect to this Agreement shall be addressed to             , Attention:             and any communication from the Warrant
Agent to the Company with respect to this Agreement shall be addressed to Cell Therapeutics, Inc., 501 Elliott Avenue West, Suite 400, Seattle, Washington, 98119, Attention: Executive Vice President, Finance & Administration (or such other
address as shall be specified in writing by the Warrant Agent or by the Company). 
  
 6.4 Governing Law. This Agreement and each Warrant Certificate issued hereunder shall be governed by and construed in accordance with the laws of the State of [Washington]. 
  
 6.5 Delivery of Prospectus. The Company shall furnish to the Warrant
Agent sufficient copies of a prospectus meeting the requirements of the Securities Act of 1933, as amended, relating to the Warrant Debt Securities deliverable upon exercise of the Warrants (the “Prospectus”), and the Warrant Agent agrees
that upon the exercise of any Warrant, the Warrant Agent will deliver to the holder of the Warrant Certificate evidencing such Warrant, prior to or concurrently with the delivery of the Warrant Debt Securities issued upon such exercise, a
Prospectus. 
  
 The Warrant Agent shall not, by reason of any such
delivery, assume any responsibility for the accuracy or adequacy of such Prospectus. 
  
 6.6 Obtaining of Governmental Approvals. The Company will from time to time take all action which may be necessary to obtain and keep effective any and all permits, consents and approvals of governmental
agencies and authorities and securities act filings under United States Federal and state laws (including without limitation a registration statement in respect of the Warrants and Warrant Debt Securities under the Securities Act of 1933, as
amended), which may be or become requisite in connection with the issuance, sale, transfer, and delivery of the Warrant Debt Securities issued upon exercise of the Warrants, the issuance, sale, transfer and delivery of the Warrants or upon the
expiration of the period during which the Warrants are exercisable. 
  
 6.7 Persons Having Rights Under Warrant Agreement. Nothing in this Agreement shall give to any person other than the Company, the Warrant Agent and the holders of the Warrant Certificates any right, remedy or claim under or by reason
of this Agreement. 
  
 6.8 Headings. The descriptive
headings of the several Articles and Sections of this Agreement are inserted for convenience only and shall not control or affect the meaning or construction of any of the provisions hereof. 
  

 -11- 

 6.9 Counterparts. This Agreement may be executed in any number of counterparts, each of which as
so executed shall be deemed to be an original, but such counterparts shall together constitute but one and the same instrument. 
  
 6.10 Inspection of Agreement. A copy of this Agreement shall be available at all reasonable times at the principal corporate trust office of the
Warrant Agent for inspection by the holder of any Warrant Certificate. The Warrant Agent may require such holder to submit his Warrant Certificate for inspection by it. 
  
 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed, all as of the day and year
first above written. 
  

					
	 	 	CELL THERAPEUTICS, INC.
			
	 	 	By:	 	  

	 	 	Its:	 	  

	Attest:	 	 
	  
  

	 	  
  
  

	 	 	Warrant agent
			
	 	 	By:	 	  

	 	 	Its:	 	  

  
 [SIGNATURE PAGE TO DEBT
SECURITIES WARRANT AGREEMENT] 
  

 -12- 

 EXHIBIT A 
  
 FORM OF WARRANT CERTIFICATE 
 [Face of Warrant
Certificate] 
  

			
	[Form if Warrants are attached to Other Securities and are not immediately detachable.	 	Prior to            , this Warrant Certificate cannot be transferred or exchanged unless attached to a [Title of Other
Securities].]
		
	[Form of Legend if Warrants are not immediately exercisable.	 	Prior to            , Warrants evidenced by this Warrant Certificate cannot be exercised.]

  
 EXERCISABLE ONLY IF
COUNTERSIGNED BY THE WARRANT AGENT 
 AS PROVIDED HEREIN 
  
 VOID AFTER [        ] P.M., [CITY] TIME, ON
            , 
  
 CELL THERAPEUTICS, INC. 
  
 WARRANT
CERTIFICATE REPRESENTING 
 WARRANTS TO PURCHASE 
 [TITLE OF WARRANT DEBT SECURITIES] 
  

			
	No.	 	Warrants

  
 This certifies that
             or registered assigns is the registered owner of the above indicated number of Warrants, each Warrant entitling such owner [If Warrants are attached to Other Securities and are
not immediately detachable—, subject to the registered owner qualifying as a “Holder” of this Warrant Certificate, as hereinafter defined)] to purchase, at any time [after [        ] p.m.,
[City] time, on              and] on or before [        ] p.m., [City] time, on
            , $              principal amount of [Title of Warrant Debt Securities] (the “Warrant Debt
Securities”), of Cell Therapeutics, Inc. (the “Company”), issued or to be issued under the Indenture (as hereinafter defined), on the following basis: during the period from
            , through and including             , each Warrant shall entitle the Holder thereof, subject to the provisions of
this Agreement, to purchase the principal amount of Warrant Debt Securities stated in the Warrant Certificate at the warrant price (the “Warrant Price”) of         % of the principal
amount thereof [plus accrued amortization, if any, of the original issue discount of the Warrant Debt Securities] [plus accrued interest, if any, from the most recent date from which interest shall have been paid on the Warrant Debt Securities or,
if no interest shall have been paid on the Warrant Debt Securities, from the date of their original issuance]. [The original issue discount ($             for each $1,000 principal amount
of Warrant Debt Securities) will be amortized at a         % annual rate, computed on a[n] [semi-]annual basis [using a 360-day year consisting of twelve 30-day months]. The Holder may exercise the Warrants
evidenced hereby by providing 

  

 A-1 

 
certain information set forth on the back hereof and by paying in full, in lawful money of the United States of America, [in cash or by certified check or
official bank check in New York Clearing House funds] [by bank wire transfer in immediately available funds], the Warrant Price for each Warrant Debt Security with respect to which this Warrant is exercised to the Warrant Agent (as hereinafter
defined) and by surrendering this Warrant Certificate, with the purchase form on the back hereof duly executed, at the corporate trust office of [name of Warrant Agent], or its successor as warrant agent (the “Warrant Agent”), which is, on
the date hereof, at the address specified on the reverse hereof, and upon compliance with and subject to the conditions set forth herein and in the Warrant Agreement (as hereinafter defined). 
  
 The term “Holder” as used herein shall mean [if
Warrants are attached to Other Securities and are not immediately detachable—, prior to [             ,             ] (the
“Detachable Date”), the registered owner of the Company’s [title of Other Securities]to which this Warrant Certificate was initially attached, and after such Detachable Date,] the person in whose name at the time this
Warrant Certificate shall be registered upon the books to be maintained by the Warrant Agent for that purpose pursuant to Section 4 of the Warrant Agreement. 
  
 The Warrants evidenced by this Warrant Certificate may be exercised to purchase a whole number of Warrant Securities in
registered form. Upon any exercise of fewer than all of the Warrants evidenced by this Warrant Certificate, there shall be issued to the Holder hereof a new Warrant Certificate evidencing Warrants for the number of Warrant Securities remaining
unexercised. 
  
 This Warrant Certificate is issued under and in
accordance with the Warrant Agreement dated as of [                    ,             ]
(the “Warrant Agreement”), between the Company and the Warrant Agent and is subject to the terms and provisions contained in the Warrant Agreement, to all of which terms and provisions the Holder of this Warrant Certificate
consents by acceptance hereof. Copies of the Warrant Agreement are on file at the above-mentioned office of the Warrant Agent. 
  
 The Warrant Debt Securities to be issued and delivered upon the exercise of Warrants evidenced by this Warrant Certificate will be issued under and in
accordance with an Indenture, [dated as of                     ,             (the
“Senior Indenture”), between the Company and             ,             as trustee (such trustee, and any
successors to such trustee, the “Senior Trustee”)] [dated as of                     ,
            , (the “Subordinated Indenture”), between the Company and             , as trustee (such
trustee, and any successors to such trustee, the “Subordinated Trustee”)] and will be subject to the terms and provisions contained in the Warrant Debt Securities and in the Indenture. Copies of the [Senior] [Subordinated]
Indenture, including the form of the Warrant Debt Securities, are on file at the corporate trust office of the Trustee. 
  
 [If Warrants are attached to Other Securities and are not immediately detachable—Prior to the Detachable Date, this Warrant Certificate may be
exchanged or transferred only together with the [Title of Other Securities] (the “Other Securities”) to which this Warrant Certificate was initially attached, and only for the purpose of effecting or in conjunction with, an
exchange or transfer of such Other Security. Additionally, on or prior to the Detachable Date, each transfer of such Other Security on the register of the Other Securities shall operate also to transfer this Warrant Certificate. After such date,
transfer of this] [If Warrants are attached to Other Securities 

  

 A-2 

 
and are immediately detachable—Transfer of this] Warrant Certificate may be registered when this Warrant Certificate is surrendered at the corporate
trust office of the Warrant Agent by the registered owner or such owner’s assigns, in the manner and subject to the limitations provided in the Warrant Agreement. 
  
 [If Other Securities with Warrants which are not immediately detachable—Except as provided in the immediately preceding
paragraph, after] [If Other Securities with Warrants which are immediately detachable or Warrants alone—After] countersignature by the Warrant Agent and prior to the expiration of this Warrant Certificate, this Warrant Certificate may be
exchanged at the corporate trust office of the Warrant Agent for Warrant Certificates representing Warrants for the same aggregate number of Warrant Securities. 
  

This Warrant Certificate shall not entitle the Holder hereof to any of the rights of a holder of the Warrant Securities, including, without limitation,
the right to receive payments of dividends or distributions, if any, on the Warrant Securities (except to the extent set forth in the Warrant Agreement) or to exercise any voting rights. 
  
 Reference is hereby made to the further provisions of this Warrant Certificate set forth on the reverse hereof, which
further provisions shall for all purposes have the same effect as if set forth at this place. 
  
 This Warrant Certificate shall not be valid or obligatory for any purpose until countersigned by the Warrant Agent. 
  
 IN WITNESS WHEREOF, the Company has caused this Warrant to be executed in its name and on its behalf by the facsimile signatures of its duly
authorized officers. 
  

							
	 	 	 	 	CELL THERAPEUTICS, INC.
	Dated:	 	  

	 	 	 	 
	 	 	 	 	By:	 	  
  

	 	 	 	 	Its:	 	  
  

	Attest:	 	 	 	 	 	 
	  
  

	 	 	 	 
	  
 Countersigned:
	 	 	 	 
	  
  

	 	 	 	 

							
	As warrant Agent	 	 	 	 
				
	By:	 	  

	 	 	 	 
	 	 	Authorized Signature	 	 	 	 

  
 [REVERSE OF WARRANT
CERTIFICATE] 
  

 A-3 

 (Instructions for Exercise of Warrant) 
  
 To exercise any Warrants evidenced hereby for Warrant Securities (as hereinafter defined), the Holder must pay, in lawful
money of the United States of America, [in cash or by certified check or official bank check in New York Clearing House funds] [by bank wire transfer in immediately available funds], the Warrant Price in full for Warrants exercised, to [Warrant
Agent] [address of Warrant Agent], Attn: [                    ], which payment must specify the name of the Holder and the number of Warrants
exercised by such Holder. In addition, the Holder must complete the information required below and present this Warrant Certificate in person or by mail (certified or registered mail is recommended) to the Warrant Agent at the appropriate address
set forth above. This Warrant Certificate, completed and duly executed, must be received by the Warrant Agent within five business days of the payment. 
  
 (To be executed upon exercise of Warrants) 
  
 The undersigned hereby irrevocably elects to exercise              Warrants, represented by
this Warrant Certificate, to purchase $              principal amount of the [Title of Warrant Debt Securities] (the “Warrant Debt Securities”) of Cell Therapeutics,
Inc. and represents that he has tendered payment for such Warrant Debt Securities, in lawful money of the United States of America, [in cash or by certified check or official bank check in New York Clearing House funds] [by bank wire transfer in
immediately available funds], to the order of Cell Therapeutics, Inc., c/o [insert name and address of Warrant Agent], in the amount of $              in accordance with the terms hereof.
The undersigned requests that said principal amount of Warrant Debt Securities be in fully registered form in the authorized denominations, registered in such names and delivered all as specified in accordance with the instructions set forth below.

  
 If the number of Warrants exercised is less than all the
Warrants evidenced hereby, the undersigned requests that a new Warrant Certificate evidencing the Warrants for the aggregate principal amount of Warrant Debt Securities remaining unexercised be issued and delivered to the undersigned unless
otherwise specified in the instructions below. 
  

							
	Dated:	 	  

	 	Name:	 	  
  

	 	 	 	 	(Please Print)
	 	 	 	 	Address:	 	  
  

			
	 	 	 	 	  

			
	 	 	 	 	  

	 	 	 	 	(Insert Social Security or Other Identifying Number of Holder)
	Signature Guaranteed	 	  
  

	 	 	Signature
			
	 	 	 	 	(Signature must conform in all respects to name of holder as specified on the face of this Warrant Certificate and must bear a signature guarantee by a bank, trust company or
member broker of the New York, Midwest or Pacific Stock Exchange)

  

 A-4 

 This Warrant may be exercised at the following addresses: 
  

			
	By hand at	 	  

	 	 	  

	By mail at	 	  

	 	 	  

  
 [Instructions as to form and delivery
of Warrant Securities and, if applicable, Warrant Certificates evidencing Warrants for the number of Warrant Securities remaining unexercised—complete as appropriate.] 
  
 ASSIGNMENT 
  
 [Form of assignment to be executed if Warrant Holder desires to transfer Warrant) 
  

			
	FOR VALUE RECEIVED,	    	hereby sells, assigns and transfers unto:
	  
  

	    	  

	  
  

	    	  

	(please print name and address including zip code)	    	Please insert Social Security or other Identifying number

  
 the right represented
by the within Warrant to purchase [            ] shares of [Title of Warrant Securities] of Cell Therapeutics, Inc. to which the within Warrant relates and appoints
[            ] attorney to transfer such right on the books of the Warrant Agent with full power of substitution in the premises. 
  

					
	Dated	 	  
  

	 	

	 	 	 	 	Signature
			
	 	 	 	 	(Signature must conform in all respects to name of holder as specified on the face of the Warrant)
		
	Signature Guaranteed	 	 
	  
  

	 	 

  

 A-5Resignation Agreement

 Exhibit 10.1 
  
 RESIGNATION AGREEMENT AND RELEASE 
  
 This Resignation Agreement and Release (this “Agreement”) is made and entered into by and between
MICHAEL T. WILLIS (“Executive”), a resident of Houston, Harris County, Texas, and COMSYS INFORMATION TECHNOLOGY SERVICES, INC. (the “Company”), as of the date set forth on the signature page attached
hereto (the “Date of this Agreement”). 
  
 Executive has been employed by the Company pursuant to that certain Amended and Restated Employment Agreement, dated December 30, 2003, as amended by written amendment dated November 28, 2005 (collectively, the
“Executive’s Employment Agreement”), as the Company’s Chairman of the Board of Directors, Chief Executive Officer and President. Executive also serves as a director of COMSYS IT Partners, Inc. (“CITP”),
the Company’s parent, and as a director of one or more of the Company’s subsidiaries. Executive has decided to resign from all positions with the Company, CITP and their respective subsidiaries, and the parties wish to provide for
the orderly transition of Executive’s duties and responsibilities. 
  
 This Agreement sets forth the terms upon which Executive and the Company have agreed to end Executive’s employment with the Company. For and in consideration of the mutual promises of the parties contained herein and other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 
  

	1.	Executive’s Resignation from Employment and all Company Positions. 

  

	 	a.	Resignation from Employment. Executive has resigned from and hereby confirms his resignation from employment with the Company, CITP and each of their respective direct
and indirect subsidiaries. Executive’s employment with the Company will be deemed to have been terminated on February 2, 2006 (the “Resignation Date”). 

  

	 	b.	Resignation from all Offices and Positions on Boards. Executive has resigned from and hereby confirms his resignation from all positions and offices, if any, that he
holds or has held at any time with the Company, CITP and their respective subsidiaries, and from all positions and offices, if any, that he holds or has held at any time with the Board of Directors (and all committees thereof) of the Company, CITP
and each of their respective direct and indirect subsidiaries, predecessors and affiliates, effective as of the Resignation Date. If requested by the Company, Executive will execute any additional resignation letters, forms or other documents which
acknowledge Executive’s resignation from such employment, offices, committees and positions. 

  

	2.	Executive’s Separation Benefits. 

  

	 	a.	Separation Payments. As consideration provided for the covenants and agreements set forth herein and in full satisfaction of all claims Executive has or may have
against the Company and the Released Parties (as defined in Section 4) by reason of anything done or omitted to be done in relation to Executive’s employment with the Company, up to the Date of this Agreement, the Company shall pay to
Executive an amount equal to One 

 Million Dollars ($1,000,000) (i.e., two times the Executive’s Annual Base Salary (as defined
in Executive’s Employment Agreement) as of the Resignation Date), which shall be paid as follows: (i) $500,000.00 shall be paid within ten (10) business days after the Effective Date and (ii) the balance shall be paid in in
forty-eight (48) semi-monthly installments of $10,416.67 during the two year period (“the Severance Period”) following the Effective Date (as defined in Section 5) in accord with the Company’s regular payroll
procedures. In addition, on December 31, 2006, the Company shall pay a single one separate severance payment to Executive equal to $150,000 on December 31, 2006 (such installments and single payment, together with the Consulting Fee
defined in Section 3 below, the other payments and benefits provided under this Agreement, the “Separation Benefits”). 
  

	 	b.	Vacation and Personal Leave Time. Executive will, on the Date of this Agreement, report all paid time off and vacation leave taken through the Resignation Date. In
addition to the Separation Benefits, the Company will pay to Executive a lump sum amount relating to any unused accrued vacation and leave compensation Executive may have as of the Resignation Date on the first regularly-scheduled payroll date after
the Date of this Agreement, in accordance with the Company’s existing paid time off and vacation policies. 

  

	 	c.	Continued Medical Coverage. Executive has had coverage of medical expenses under the Company’s health insurance plan. The Company acknowledges that Executive has
the right to continue coverage after the Resignation Date under the COBRA provisions of federal law and under applicable provisions of Texas law. The Company will reimburse Executive his COBRA coverage continuation premium or premiums for third
party health insurance from the Effective Date until the earlier of (i) Executive’s sixty-fifth (65th) birthday or (ii) the date Executive becomes eligible for medical insurance coverage under a new or subsequent employer’s plan; provided, that the aggregate amount payable by the Company pursuant to this
Section 2(c) shall not exceed $1,000 per month. Executive agrees to provide the Company with any information or forms required to make payments to effect this coverage. Executive shall inform the Company upon acceptance of any new employment
and eligibility for health care coverage as a result of such employment, if any, during the Severance Period. 

  

	 	d.	Reimbursement of Existing Expenses. Not later than March 31, 2006, Executive shall submit to the Company reimbursement requests for all out-of-pocket expenses
incurred by Executive prior to the Resignation Date and which are reimbursable to Executive in accordance with the Company’s existing policies and procedures. Executive acknowledges that he shall not be entitled to any reimbursement for
(i) any such expense not reported to the Company on or prior to March 31, 2006 or (ii) any expense by Executive from and after the Resignation Date (including without limitation travel and entertainment expenses, club dues and
membership fees) except as expressly set forth in Sections 2(c) and 2(e). 

  

	 	e.	Expense Allowance. The Company will pay to Executive, a monthly expense allowance of $8,250.00 payable on the last business day of each month, in arrears, commencing
February 28, 2006, as reimbursement for a mutually agreeable estimate of Executive’s expenses incurred in connection with the preparation and negotiation of this agreement and 

  

 2 

 for out-of-pocket expenses incurred by Executive in connection with Executive’s separation of
employment with the Company and efforts to seek other employment, including without limitation: outplacement assistance, personal or professional counseling or coaching services, and legal and tax consulting services. Irrespective of the actual
amount of such expenses or of any other expenses incurred by Executive, Executive shall not be entitled to any other payment of or reimbursement for expenses except as set forth in Section 2(d), this Section 2(e) and Section 3(c).

  

	 	f.	Equity Incentive Plan. Executive acknowledges that pursuant to the COMSYS Holding, Inc. 2004 Management Incentive Plan, his award agreement thereunder and any related
documents or instruments (collectively, the “Equity Plan Documents”), (i) after the Date of this Agreement Executive will hold 282,703 vested shares of common stock of CITP, (ii) notwithstanding the termination of
Executive’s employment with the Company, an additional 204,109 shares of CITP common stock shall vest if, and only if, the average closing price for such common stock over any consecutive 30-day period ending on or before December 31,
2006, equals or exceeds $18.67, as adjusted for any stock split, stock dividend, or combination of shares, (iii) no other shares of such common stock will vest to Executive, (iv) Executive shall not be entitled to any further shares under
the Equity Plan Documents and (v) the release set forth in Section 3 below applies to all claims under the Equity Plan Documents.. Schedule A attached hereto outlines the Executive’s vested and unvested shares as of the Resignation
Date. 

  

	 	g.	Payment of the Separation Benefit. The amounts payable under this Agreement may constitute ordinary compensation income and be payable to Executive less required
payroll deductions and authorized withholdings. 

  

	 	h.	No Prior Entitlement to Separation Benefit. The parties agree the Separation Benefits include substantial consideration in addition to anything of value to which
Executive was already entitled before signing this Agreement. 

  

	 	i.	Forfeiture of Benefits. In the event that Executive (i) violates the provisions of Section 8 of this Agreement or (ii) materially violates any other
provision of this Agreement, including but not limited to the provisions of Section 7 and Sections 9 through 12 (an event under clause (i) or (ii) is hereinafter a “Default”), then Executive shall forfeit all unpaid
Separation Benefits to which he may be entitled hereunder, and thereupon the Company’s obligations to provide the Separation Benefits shall terminate; provided, that nothing herein shall be construed as prohibiting the Company from
pursuing any other remedies available to the Company in the event of any breach or threatened breach, or as a waiver of the Company’s right to seek specific performance or injunctive relief to enforce this Agreement’s restrictive
covenants. 

  

	 	j.	No Duty to Mitigate. Executive shall not be required to mitigate the amount of any payment or other benefit required to be paid to Executive pursuant to this
Agreement, whether by seeking other employment or otherwise. Except as set forth in Section 2(c) above, the amount of the payments to be received hereunder shall not be reduced on account of any compensation earned by Executive as a result of
employment by another person. 

  

 3 

	3.	Consulting Services. 

  

	 	a.	Description of Services. During the Consulting Period (as defined in Section 3(f) below), in further consideration of the Separation Benefits, Executive shall
provide consulting services to the Company as and to the extent reasonably requested by the Company’s acting or permanent chief executive officer. Executive shall diligently and in good faith use Executive’s best efforts in the performance
of the services hereunder. The services shall be performed in a manner (e.g., time and location) mutually agreeable between Executive and Company and subject to the following terms: 

  

	 	b.	Consulting Fee. The Company shall pay to Executive a consulting fee in the amount of $105,000 (the “Consulting Fee”), payable on July 31, 2006.

  

	 	c.	Reimbursement of Consulting Expenses. The Company shall reimburse Executive for all out-of-pocket expenses that were approved in advance in writing by the
Company’s Chief Executive Officer and that were incurred by Executive in connection with providing consulting services to the Company during the Consulting Period in accordance with the Company’s existing policies and procedures.

  

	 	d.	Temporary Office Space; Secretarial Support. The Company shall provide Executive with an office located at (a) the Company’s executive offices in Houston,
Texas until the earlier of February 28, 2006 or the termination of the Consulting Period and (b) thereafter at an off-site location approved by the Company’s Board of Directors for the remaining duration, if any, of the Consulting
Period. In addition, the Company shall permit Bernice Arcenaux to continue to provide secretarial support to Executive during the Consulting Period. 

  

	 	e.	No Authority of Executive. Executive shall have no authority to accept, and shall not in any manner accept, any offer to purchase products or services on behalf of the
Company or otherwise commit or bind the Company. Executive does and will not have, and shall not hold Executive out as having, any right, power or authority (a) to create any contract or obligation, either express or implied, on behalf of, in
the name of, or binding upon the Company or (b) to accept legal process on behalf of the Company. 

  

	 	f.	Hold Harmless. Executive agrees to indemnify and hold the Company harmless from and against any and all losses, claims, demands, liabilities and damages, including
without limitation reasonable attorneys’ fees and court costs, in any manner arising out of, relating to or in connection with Executive’s grossly negligent or willful acts or omissions in the performance of services hereunder.

  

	 	g.	Independent Executive Status. After the Resignation Date, Executive shall be treated for all purposes as an independent Executive and not as an employee of the
Company. Executive shall not be under the supervision or control of the Company and shall carry out Executive’s obligations hereunder independent of the Company. Executive shall be liable for Executive’s own debts, obligations, acts and
omissions, including the payment of all withholding, Social Security and other taxes and benefits. As an independent Executive, Executive is responsible for filing such tax returns and paying such self-employment taxes 

  

 4 

 as may be required by law or regulations. Executive shall not be eligible for any employee benefit plan
offered by the Company. In the event that this independent Executive relationship is determined by tax authorities to constitute an employment relationship, Executive hereby waives any and all claims to coverage under any Company pension,
profit-sharing, health, dental, welfare or similar type plans which are generally limited to the Company’s employees, unless otherwise agreed by the Company in writing. Further, Executive hereby agrees to indemnify and hold the Company harmless
from and against any and all claims, liabilities, costs and expenses (including reasonable attorneys’ fees) relating to any determination or claim that Executive is acting in a capacity other than as an independent Executive hereunder after the
Resignation Date. 
  

	 	h.	Consulting Period. The “Consulting Period” shall commence on the Effective Date and shall end on April 30, 2006; provided, that the Company may
terminate the Consulting Period prior to such date upon written notice to Executive if the Company determines that Executive has (i) committed a Default, (ii) except as expressly requested in writing by the Company’s Chief Executive
Officer pursuant to Section 3(a) above, (A) contacted any Company employee, customer, supplier, stockholder, affiliate, lender, investment banker or other service provider regarding the Company or any Released Party or (B) conducted
or attempted to conduct any business on behalf of the Company, or (iii) otherwise failed to follow any lawful directive of the Company’s Chief Executive Officer or Board of Directors. 

  

	4.	Release. 

  

	 	a.	Release of Claims. Executive, on behalf of Executive and Executive’s attorneys, attorneys-in-fact, heirs, executors, administrators, successors, and assigns, does
hereby fully release and discharge the Company, CITP, their subsidiaries and affiliates and each of their respective directors, officers, employees, agents, attorneys, consultants, investment bankers, underwriters, stockholders, members, partners,
predecessors, successors, and assigns (the “Released Parties”), of and from any and all debts, sums of money, fees, claims, charges, demands, actions, causes of action, notes, liabilities and obligations, of whatever nature, in law,
equity or otherwise, whether the same be known or unknown, whether the same be liquidated, unliquidated, contingent or otherwise, and whether the same be in contract (express or implied), in tort or otherwise, which Executive ever had or now has (or
hereafter can, shall or may have) with respect to anything done or omitted to be done up to the Date of this Agreement. The claims released and discharged hereby include any claims against any third party, which is or might become the subject of an
indemnity proceeding (contractual or otherwise) initiated or threatened by such third party against the Company. They also include but are not limited to (i) any and all claims related to Executive’s employment with the Company, its
predecessors, subsidiaries and affiliates and the termination of same; (ii) any and all claims for additional compensation or benefits other than the compensation and benefits described in this Agreement, including but not limited to wages,
commissions, deferred compensation, bonuses, incentive plan, stock option or restricted stock awards, or other benefits of any kind; (iii) any and all claims relating to employment practices or policies of the Company or its affiliates;
(iv) any and all claims under any express or implied employment contract (including Executive’s Employment Agreement) with Executive which Executive’s 

  

 5 

 successors, assigns, or representatives may claim existed with the Company or any of the Released
Parties; and (v) any and all claims arising under any state or federal legislation, including, but not limited to, those claims arising under the National Labor Relations Act, as amended, 29 U.S.C. §§ 151–169; Title VII of the
Civil Rights Act of 1964, as amended, 42 U.S.C. §§ 2000e to 2000e-17; the Age Discrimination in Employment Act, 29 U.S.C. §§ 621–634; the Uniformed Services Employment and Reemployment Rights Act of 1994, 38 U.S.C.
§§ 4301–4334; the Civil Rights Acts of 1866 and 1871, as amended, 42 U.S.C. §§ 1981–1983; the Americans with Disabilities Act of 1990, 42 U.S.C. §§ 12101–12213; the Employee Retirement Income
Security Act of 1974, 29 U.S.C. §§ 1001–1461; the Consolidated Omnibus Budget Reconciliation Act of 1985, 29 U.S.C. §§ 1161–1169; the Family and Medical Leave Act, 29 U.S.C. §§ 2601–2654; and the
Fair Labor Standards Act, 29 U.S.C. §§ 201-219; provided, that the foregoing shall not release the Executive’s right to be indemnified against liabilities, or to benefit from provisions limiting the Executive’s liability,
to the extent provided in the certificate of incorporation or bylaws of the Company, CITP or any of their respective subsidiaries. Executive understands that Executive is releasing claims that Executive may not know about at this time, and that is
Executive’s intent. Executive expressly waives all rights Executive might have under any law that is intended to prevent unknown claims from being released and understands the significance of doing so. 
  

	 	b.	Release of Future Actions. Executive further agrees not to bring any action, suit or other proceeding (whether before any court, judicial or administrative authority,
arbitrator or otherwise) against any Released Party to enforce any of the claims released and discharged hereby and agrees that this Agreement shall be an absolute bar to any such action, suit or other proceeding. The Executive also agrees not to
bring any action against, and hereby releases any and all claims that he might have against, the Released Parties relating to the management of the Company from the Resignation Date to and including December 31, 2006, except for claims that he
might have as the result of his status as a Company shareholder during that period and for claims arising from the Company’s breach of this Release Agreement. 

  

	 	c.	Bonus. Executive acknowledges that no bonus was earned or is payable under Executive’s Employment Agreement for fiscal years 2003, 2004 or 2005. Further,
Executive acknowledges that he shall not be entitled to a bonus for the Company’s fiscal year ending December 31, 2006 irrespective of the Company’s or CITP’s performance during 2006. 

  

	5.	Provision Relating to ADEA Release. Executive represents to the Company that Executive is aware, understands and agrees that: 

  

	 	a.	Executive is voluntarily entering into and signing this Agreement; 

  

	 	b.	the claims waived, released and discharged in Section 4 of this Agreement include any and all claims Executive has or may have arising out of or related to
Executive’s employment with the Company or termination of that employment, including any and all claims under the Age Discrimination in Employment Act (the “ADEA”); 

  

 6 

	 	c.	those claims waived, released and discharged in Section 4 hereunder do not include, and Executive is not waiving, releasing or discharging, any claims that may arise and
relate to periods or actions occurring after the Date of this Agreement; 

  

	 	d.	payment of the Separation Benefits pursuant to Section 2 hereunder includes and provides additional consideration that Executive was not entitled to receive before
signing this Agreement; 

  

	 	e.	Executive was given twenty-one (21) days within which to consider this Agreement, but Executive has been informed that Executive may waive this twenty-one day
consideration period and elect to execute this document prior to the expiration of the twenty-one day consideration period, in order to expedite the execution of this Agreement and the payment of the Benefits; and THAT IF EXECUTIVE SIGNS AND
DELIVERS THIS AGREEMENT PRIOR TO THE EXPIRATION OF SUCH TWENTY-ONE DAY PERIOD, THEN HE EXPRESSLY HEREBY WAIVES HIS RIGHTS TO THE REMAINDER OF SUCH TWENTY-ONE DAY PERIOD; and 

  

	 	f.	Executive has and has had the right to consult with an attorney regarding this Agreement before signing this Agreement; Executive acknowledges that the Company has advised
Executive to consult with an attorney and that Executive has obtained such legal counsel as Executive deems necessary, such that Executive is entering into this Agreement freely, knowingly and voluntarily; 

  

	 	g.	Executive may revoke this Agreement at any time within seven (7) days after the day Executive signs this Agreement (that is, at any time within seven (7) days after
the Date of this Agreement), and this document will not become effective or enforceable and no payments under this Agreement will be payable until the eighth day after the Date of this Agreement without prior revocation by Executive, on which day
(the “Effective Date”), this Agreement will automatically become effective and enforceable unless previously revoked within that seven-day period; and 

  

	 	h.	EXECUTIVE HAS CAREFULLY READ THIS DOCUMENT, AND FULLY UNDERSTANDS EACH AND EVERY TERM. 

  

	6.	No Assignment of Claims by Executive. Executive represents and warrants that Executive has not assigned or transferred or purported to assign or transfer to any person
or entity any legal claims against the Company or any portion thereof or interest therein and shall not, after the execution of this Agreement, assign or attempt to assign any such claim or interest. 

  

	7.	Return of Company Property. On or before the Date of this Agreement, Executive shall return to the Company all Company property that Executive has had in
Executive’s possession at any time, including, but not limited to, Company records, documents, tools, credit cards, entry cards, identification cards, identification badges, keys, key fobs, laptop computers, computer software, diskettes, tapes,
passwords, sales materials, personnel data, handheld devices, all equipment issued by the Company to Executive, and any materials of any kind which contain or embody any proprietary or confidential information of the Company (and all reproductions
thereof). 

  

 7 

	8.	Non-Disparagement. Executive shall not disparage or make derogatory comments about the Company, or any of the Released Parties, in any manner or form, in relation to
Executive’s employment or retirement from employment with the Company. The Company and its officers will likewise refrain from making negative or derogatory comments about Executive. 

  

	9.	Confidential and Proprietary Information. Executive explicitly acknowledges, reaffirms and agrees that he shall continue to be bound by Executive’s
post-employment obligations contained in Executive’s Employment Agreement to preserve the confidentiality of the Company’s confidential information, including without limitation those limitations set forth in Section 5 of
Executive’s Employment Agreement. 

  

	10.	Restrictive Covenant. Executive explicitly acknowledges, reaffirms and agrees that he shall continue to be bound by Executive’s post-employment restrictive
covenants with the Company contained in Executive’s Employment Agreement, including, but not limited to, those restrictions set forth in Section 6 of Executive’s Amended and Restated Employment Agreement dated December 30, 2003,
provided, however, that the Executive shall not be subject to the noncompetition restriction set forth in Section 6(a) thereof. 

  

	11.	Cooperation in Litigation and Other Legal Matters. During the Severance Period, Executive agrees that in the event information or assistance is needed from Executive
by the Company to defend or establish any legal claims, Executive will cooperate with the Company in providing the assistance and information. Executive’s assistance and cooperation shall include, but not be limited to, providing informal
interviews with the Company or its representatives; supplying affidavits; appearing at and providing testimony in depositions, hearings, arbitrations, administrative proceedings (including but not limited to Equal Employment Opportunity Commission
and National Labor Relations Board proceedings), and state and federal court trials. This assistance and cooperation requirement shall apply to any pending grievances, charges or litigation, and all future grievances, charges or litigation. Both
parties agree to act reasonably and in good faith in scheduling the dates, times and length of time during which Executive will perform consulting services and provide assistance and cooperation in litigation. In the event that Executive is needed
by the Company to appear at and provide testimony in depositions, hearings, arbitrations, administrative proceedings or trials, the Company shall reimburse Executive for reasonable expenses incurred in providing such consultation and making himself
available, including attorney’s fees and costs, if necessary. 

  

	12.	Disclosure of this Agreement. 

  

	 	a.	Company Disclosure Obligations. Executive acknowledges that CITP will make public disclosure regarding Executive’s resignation and the terms of this Agreement to
the extent that CITP deems it necessary to comply with applicable laws and regulations and securities exchange listing requirements. Without limitation of the foregoing Executive acknowledges that CITP intends to (i) file a Form 8-K with the
Securities and Exchange Commission (the “SEC”) in connection with Executive’s resignation and (ii) file a copy of this Agreement as an exhibit to such filing or with CITP’s other filings with the SEC.

  

	 	b.	Press Release. The Company or CITP will issue a press release, in the form of Exhibit B hereto, announcing Executive’s resignation and will include a
statement thanking 

  

 8 

 Executive for his years of service with the Company and for other accomplishments. Such press release
will remain on the Company’s website for the one-year period following the Effective Date. 
  

	 	c.	Non-disclosure by Executive. Executive will not at any time, directly or indirectly, (i) discuss with or disclose to or discuss with anyone (other than to members
of his immediate family, his legal, tax and financial advisors, appropriate taxing authorities and certain other advisors under an obligation of confidentiality (collectively, “Qualified Persons”) the terms of this Agreement or
(ii) discuss with anyone other than Qualified Persons the circumstances surrounding the termination of his employment. 

  

	13.	Costs of this Agreement. Each party is responsible for satisfaction of its own costs, expenses, and attorney’s fees arising from the preparation, review, and
execution of this Agreement, except as otherwise set forth in Section 2(e). 

  

	14.	No Admission of Liability or Wrongdoing; Executive’s Acknowledgement and Representation of Absence of Discrimination. This Agreement and the payment of the
Separation Benefits hereunder does not constitute an admission of any wrongdoing, unlawful conduct or liability by the Company. Executive agrees not to assert that this Agreement is an admission of wrongdoing and acknowledges that the parties to
this Agreement do not believe or admit that any of them have done anything illegal. 

  

	15.	Miscellaneous. 

  

	 	a.	Binding Effect. This Agreement shall be binding upon and inure to the benefit of the Company, its successors and assigns. This Agreement shall be binding upon and
inure to the benefit of Executive, his heirs, executors and administrators. 

  

	 	b.	Choice of Law. This Agreement shall be construed under and governed by the laws of the State of Texas without giving effect to any choice or conflict of law principles
of any jurisdiction. 

  

	 	c.	Entire Agreement. This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes and cancels all prior or
contemporaneous oral or written agreements and understandings between them with respect to the subject matter hereof; provided, that the provisions of Sections 5, 6 and 7 of the Executive’s Employment Agreement shall remain in full force
and effect except as otherwise expressly modified herein. 

  

	 	d.	Severability. If any provision of this Agreement is declared invalid or unenforceable as a matter of law, such invalidity or unenforceability shall not affect or
impair the validity or enforceability of any other provision of this Agreement or the remainder of this Agreement as a whole. 

  

	 	e.	Section Headings; Interpretation. Section headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or
interpretation of this Agreement. No provision of this Agreement is to be interpreted for or against any party because that party or its legal representative drafted such provision. 

  

 9 

	 	f.	No Waiver. No waiver by any party of any breach by any other party of any provision hereof shall be deemed to be a waiver of any other breach hereof or as a waiver of
any such or other provision of this Agreement. 

  

	 	g.	Amendment. This Agreement shall not be waived, modified or amended except by a writing executed by the parties hereto, duly authorized as applicable.

  

	 	h.	Remedies. Executive acknowledges that money damages would be an inadequate remedy for any breach of this Agreement by Executive. Therefore, in the event of a breach or
threatened breach of this Agreement, the Company or its successors or assigns may, in addition to other rights and remedies existing in their favor, apply to any court of competent jurisdiction for specific performance and/or injunctive or other
relief in order to enforce, or prevent any violations of, the provisions hereof. 

  

	16.	Notices. Any notice provided for in this Agreement must be in writing and must be either personally delivered, mailed by first class mail (postage prepaid and return
receipt requested) or sent by reputable overnight courier service (charges prepaid) to the recipient at the address below indicated: 

  
 If to the Company: 
  
 COMSYS Information Technology Services, Inc. 
 4400 Post Oak Parkway, Suite 1800 
 Houston, TX 77027 
 Attention: Ken R. Bramlett, General Counsel  
  
 If to Executive: 
  
 Michael T. Willis 
 3806 Meadowlake 
 Houston, TX 77027  
  
 with a
copy to: 
  
 Michael T. Willis 
 c/o Amir Alavi, Esq. 
 Ahmad, Zavitsanos & Anaipakos P.C. 
 1221 McKinney, Suite 3460 
 Houston, Texas 77010 
  
 or such other address or to the attention of such other person as the recipient party shall have specified by prior written notice to the sending party.
Any notice under this Agreement will be deemed to have been given when so delivered or sent or, if mailed, five days after deposit in the U.S. mail. 
  

	17.	Knowing and Voluntary Agreement. Executive affirms that the only consideration for signing this Agreement are the terms stated above, and that no other promises or
agreements of any kind 

  

 10 

 have been made to or with Executive by any other person or entity whatsoever to cause Executive to sign
this Agreement, and that Executive fully understands the meaning and intent of this instrument. Executive further states that Executive has carefully read the foregoing agreement and release and knows the contents thereof and signs the same of
Executive’s own free act. 
  
 [SIGNATURE PAGE FOLLOWS]

  

 11 

 WITNESS our hand this second day of February, 2006. 
  

			
	 COMSYS INFORMATION TECHNOLOGY SERVICES, INC.

		
	By:	 	 /s/ Larry Enterline

	Name:	 	 Larry Enterline

	Title:	 	 For the Board of Directors

	Date:	 	 2/2/2006

	
	EXECUTIVE:
	
	 /s/ Michael T. Willis

	Michael T. Willis

  

			
	STATE OF TEXAS	  	)
	 	  	)
	COUNTY OF	  	)

  
 I, Bernice Arceneaux, a Notary Public
for said County and State, do hereby certify that MICHAEL T. WILLIS personally appeared before me this day and acknowledged the due execution of the foregoing instrument. 
  
 Witness my hand and official seal, this the 2nd day of February, 2006. 
  

	
	
	 /s/ Bernice Arceneaux

 Notary Public

  
 My Commission Expires: June 3, 2006 
  

 12 

 RESIGNATION 
  
 I, MICHAEL T. WILLIS do hereby resign any and all positions which I currently hold as an officer and director
(including all committees of the board) of each of COMSYS IT Partners, Inc., COMSYS Information Technology Services, Inc. and each of their respective subsidiaries and affiliates, effective immediately. 
  
 Dated and effective as of: February 2, 2006 
  

	
	
	  

 MICHAEL T.
WILLIS

  

 13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}]]